FDA Raises Number of Potential Heparin Related Deaths to 21

David Lowe

Attorney
(866) 735-1102 Ext 665

0 CommentsPrint ArticleSubscribe

Today's New York Times reports that as many as 21 deaths may be linked to the drug heparin, and the number of reported adverse reactions (mostly decreased or low blood pressure and fast heart rate) has risen to 448, according to the FDA.

Baxter International, whose heparin seems to be involved with the problems, announced that it was expanding a recall to include most of its heparin products, including multidose vials, single-dose vials and its diluted solution of heparin used to keep blood clots from forming in intravenous lines.

The FDA investigation has revealed problems associated with unregulated local suppliers to a wholesaler that provided ingredients to the Chinese plant, but the root cause is yet to be determined.